CN105254590A - 沃替西汀氢溴酸盐新晶型及其制备方法和用途 - Google Patents
沃替西汀氢溴酸盐新晶型及其制备方法和用途 Download PDFInfo
- Publication number
- CN105254590A CN105254590A CN201410197164.8A CN201410197164A CN105254590A CN 105254590 A CN105254590 A CN 105254590A CN 201410197164 A CN201410197164 A CN 201410197164A CN 105254590 A CN105254590 A CN 105254590A
- Authority
- CN
- China
- Prior art keywords
- crystal form
- phenyl
- piperazine
- preparation
- dimethylphenyl sulfenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410197164.8A CN105254590B (zh) | 2014-05-09 | 2014-05-09 | 沃替西汀氢溴酸盐晶型及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410197164.8A CN105254590B (zh) | 2014-05-09 | 2014-05-09 | 沃替西汀氢溴酸盐晶型及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105254590A true CN105254590A (zh) | 2016-01-20 |
CN105254590B CN105254590B (zh) | 2019-09-03 |
Family
ID=55094581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410197164.8A Active CN105254590B (zh) | 2014-05-09 | 2014-05-09 | 沃替西汀氢溴酸盐晶型及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105254590B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107954947A (zh) * | 2016-10-14 | 2018-04-24 | 北京莱瑞森医药科技有限公司 | 沃替西汀氢溴酸盐晶型c及其制备方法 |
CN115716826A (zh) * | 2017-07-24 | 2023-02-28 | 生命医药有限责任公司 | RORγ的抑制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101472906A (zh) * | 2006-06-16 | 2009-07-01 | H.隆德贝克有限公司 | 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪 |
WO2013102573A1 (en) * | 2012-01-03 | 2013-07-11 | H. Lundbeck A/S | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine |
WO2014044721A1 (en) * | 2012-09-19 | 2014-03-27 | Sandoz Ag | Novel crystalline form of vortioxetine hydrobromide |
-
2014
- 2014-05-09 CN CN201410197164.8A patent/CN105254590B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101472906A (zh) * | 2006-06-16 | 2009-07-01 | H.隆德贝克有限公司 | 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪 |
WO2013102573A1 (en) * | 2012-01-03 | 2013-07-11 | H. Lundbeck A/S | Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine |
WO2014044721A1 (en) * | 2012-09-19 | 2014-03-27 | Sandoz Ag | Novel crystalline form of vortioxetine hydrobromide |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107954947A (zh) * | 2016-10-14 | 2018-04-24 | 北京莱瑞森医药科技有限公司 | 沃替西汀氢溴酸盐晶型c及其制备方法 |
CN115716826A (zh) * | 2017-07-24 | 2023-02-28 | 生命医药有限责任公司 | RORγ的抑制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN105254590B (zh) | 2019-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018219967B2 (en) | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | |
CN103974949B (zh) | 一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法 | |
EP2889298B1 (en) | 4-position substituted pyrazolopyrimidine derivative, and use thereof in drug preparation | |
CN101801381A (zh) | 新型氨基甲酰基-环己烷衍生物的溶剂合物和结晶形式 | |
CN102007138B (zh) | 吡唑衍生物的半富马酸盐 | |
CN105254590A (zh) | 沃替西汀氢溴酸盐新晶型及其制备方法和用途 | |
CN104610195B (zh) | 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途 | |
CN104628677A (zh) | 一种沃替西汀有机酸盐晶型及其制备方法 | |
CN105085473B (zh) | 来那度胺晶型及其制备方法和医药用途 | |
CN107001284B (zh) | 一种雄性激素受体抑制剂的结晶形式及其制备方法 | |
CN108250116B (zh) | 一种福多司坦晶型及其制备方法 | |
CN104974110A (zh) | 1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪氢溴酸盐的新晶型及其制备方法和用途 | |
CN106478603A (zh) | 尼洛替尼盐酸盐的新晶型及其制备方法和医药用途 | |
CN104650003A (zh) | 一种沃替西汀化合物 | |
CN107011289A (zh) | 沃替西汀β晶型的制备方法 | |
CN104974139A (zh) | 甲磺酸氟马替尼新晶型及其制备方法和医药用途 | |
CN105153066A (zh) | 盐酸沃替西汀的结晶型物及其制备方法 | |
CN106632145A (zh) | 沃替西汀氢溴酸盐晶型α的新制备方法 | |
CN104072402B (zh) | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 | |
CN105330659A (zh) | 一种利伐沙班化合物 | |
CN103880753B (zh) | 一种右美托咪定药物共晶及其制备方法 | |
CN110407762A (zh) | 一种拉莫三嗪药物共晶及其制备方法 | |
CN109928941A (zh) | 一种氢溴酸沃替西汀的结晶化合物及其制备方法 | |
CN108026068A (zh) | 哌嗪化合物的新晶体 | |
CN108285447A (zh) | 一种三嗪类化合物的晶型 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160323 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |